DeepVerge’s AGM of 26 July 2021 provided its Board with an ideal platform to highlight both the Group’s transformational past year and the exceptional opportunities it now has to deliver
Updates on Microtox® PD wastewater project
£10m funding in place to maintain significant pace of growth across the Group Consolidated group revenue increased by 445%
Microtox® PD claims world first live data alerts of SARS-Cov-2 in wastewater treatment plants
Deepverge has announced its intention to raise £10.0 million (gross) through a conditional placing and subscription (the ‘Placing’) of c.33.3 million new ordinary shares with existing and new investors at
New AI centre of excellence in Cork, Ireland to play key role in real-time detection of SARS-CoV-2 in Ireland and across Europe
DeepVerge enters into Memorandum of Understanding (“MoU”) for a Joint Venture with China Resources Environmental Protection Development Limited
Deepverge has announced that its Skin Trust Club iOS App has gone live following the successful completion of 2000 Alpha skin tests.
Skin Trust Club iOS App goes live after successful completion of 2,000 Alpha skin tests
Deepverge has published initial data from its ongoing Phase III clinical studies for the detection of SARS-CoV-2 from samples of breath condensate and identification of confirmed COVID-19 positive patients.
Microtox ® BT Evaluation of SARS-CoV-2 from breath test with Clinical Samples
